Lambert-Eaton myasthenic syndrome: evaluation of movement performance following drug therapy.
Cooke
J D
JD
Neurologische Klinik, Heinrich Heine Universität Düsseldorf, F.R.G.
Hefter
H
H
Brown
S H
SH
Toyka
K V
KV
Freund
H J
HJ
D015761:4-Aminopyridine / Q000031:analogs & derivatives / Q000627:therapeutic use; D000200:Action Potentials / Q000187:drug effects; D000328:Adult; D000077770:Amifampridine; D003131:Combined Modality Therapy; D004558:Electric Stimulation; D004576:Electromyography; D006801:Humans; D015624:Lambert-Eaton Myasthenic Syndrome / Q000188:drug therapy* / Q000503:physiopathology*; D008297:Male; D009068:Movement / Q000187:drug effects*; D010951:Plasma Exchange
D015761:4-Aminopyridine; D000077770:Amifampridine